Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 8, 2010Cancer ResearchOpen Access

Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

TMTommy MartinssonUniversity of GothenburgTETherése ErikssonStockholm UniversityJAJonas AbrahamssonSahlgrenska University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Martinsson et al. (2010) studied this question.

synapsesocial.com/papers/6a778315df493903fd1efe04https://doi.org/10.1158/0008-5472.can-10-2366
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Activation and Inhibition of Anaplastic Lymphoma Kinase Receptor Tyrosine Kinase by Monoclonal Antibodies and Absence of Agonist Activity of Pleiotrophin2005 · 158 citations
  2. 2Myoblast determination in the somatic and visceral mesoderm depends on Notch signalling as well as on<i>milliways</i>(<i>mili</i><i>Alk</i>) as receptor for Jeb signalling2004 · 77 citations
  3. 3The ligand Jelly Belly (Jeb) activates the <i>Drosophila</i> Alk RTK to drive PC12 cell differentiation, but is unable to activate the <i>Mouse</i> ALK RTK2007 · 39 citations
  4. 4High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset2010 · 246 citations